GL1X · GenesisL1 explorer

UniProt J9VSJ6

Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (J9VSJ6)

Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (UniProt J9VSJ6): 8 experimental structures on GenesisL1, 11 ligands bound, 66 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
J9VSJ6
Protein
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
Experimental structures
8
Predicted models
0
Ligands
11
Pockets
66 · 8 records with a druggable one

Structures

8 records of J9VSJ6 in the MolNFT archive: 8 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
7T08Cryptococcus neoformans protein farnesyltransferase in complex with FPP and inhibitor 2qx-ray diffractionA3FX, XO1, FPP8 (best 0.78)
7T09Cryptococcus neoformans protein farnesyltransferase in complex with FPP and inhibitor 2dx-ray diffractionA3FX, XMV, FPP8 (best 0.78)
7T0ACryptococcus neoformans protein farnesyltransferase co-crystallized with FPP and inhibitor 2fx-ray diffractionA3FX, XMY8 (best 0.76)
7T0BCryptococcus neoformans protein farnesyltransferase in complex with FPP and inhibitor 2gx-ray diffractionA3FX, XO4, FPP8 (best 0.79)
7T0CCryptococcus neoformans protein farnesyltransferase in complex with FPP and inhibitor 2ex-ray diffractionAXN4, 3FX, FPP9 (best 0.78)
7T0DCryptococcus neoformans protein farnesyltransferase in complex with FPP and inhibitor 2kx-ray diffractionASO4, 3FX, XO7, FPP10 (best 0.83)
7T0ECryptococcus neoformans protein farnesyltransferase in complex with FPP and inhibitor 2bx-ray diffractionA3FX, FPP, XOA8 (best 0.80)
8T70Cryptococcus neoformans protein farnesyltransferase in complex with FPTII and TKCMIIM peptidex-ray diffractionA3FX, FII7 (best 0.77)

Ligands

  • 3FX · (2R)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid · in 8 records
  • FPP · Farnesyl diphosphate · in 6 records
  • FII · [(3,7,11-trimethyl-dodeca-2,6,10-trienyloxycarbamoyl)-methyl]-phosphonic acid · in 1 record
  • SO4 · Sulfate ion · in 1 record
  • XMV · 4-{[5-({(2S)-2-butyl-5-oxo-4-[3-(trifluoromethoxy)phenyl]piperazin-1-yl}methyl)-1H-imidazol-1-yl]methyl}benzonitrile · in 1 record
  • XMY · (5S)-4-({1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl}methyl)-5-butyl-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one · in 1 record
  • XN4 · (5S)-5-butyl-4-({1-[(4-chlorophenyl)methyl]-1H-imidazol-5-yl}methyl)-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one · in 1 record
  • XO1 · 4-{[5-({(2S)-2-butyl-5-oxo-4-[3-(trifluoromethoxy)phenyl]piperazin-1-yl}methyl)-1H-imidazol-1-yl]methyl}-2-fluorobenzonitrile · in 1 record
  • XO4 · (5S)-5-butyl-4-({1-[(4-fluorophenyl)methyl]-1H-imidazol-5-yl}methyl)-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one · in 1 record
  • XO7 · (5S)-4-({1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl}methyl)-5-propyl-1-[3-(trifluoromethoxy)phenyl]piperazin-2-one · in 1 record
  • XOA · (5S)-4-({1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl}methyl)-5-butyl-1-(3-chlorophenyl)piperazin-2-one · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.